FHC
CAI

First Horizon Corporation’s Caris Life Sciences CAI Stock Holding History

First Horizon Corporation’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74K Buy
154
+47
+44% +$841 ﹤0.01% 1316
2026
Q1 		$1.91K Buy
+107
New +$2.34K ﹤0.01% 1279

Other funds holding CAI

ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

First Horizon Corporation's CAI Position: Q2 2026 in Review

First Horizon Corporation increased its Caris Life Sciences (CAI) stake by 44% in Q2 2026, buying an estimated $841 and bringing the position to 154 shares worth $2.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1316.

First Horizon Corporation first reported a position in CAI in Q1 2026 and has held it in 2 quarters since. 45 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • First Horizon Corporation held 154 shares of Caris Life Sciences worth $2.74K as of Q2 2026.
  • First Horizon Corporation bought 47 Caris Life Sciences shares in Q2 2026, an estimated $841.
  • Caris Life Sciences made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #1316 holding.
  • First Horizon Corporation first reported a position in Caris Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • 45 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.